IPP Bureau
Indian Pharma Market growth flat in Feb 2022
By IPP Bureau - March 09, 2022
Price was the key driver for the period
AstraZeneca partners with Indian Society of Nephrology to promote kidney health
By IPP Bureau - March 09, 2022
Under this year’s theme of ‘Kidney Health For All’, ISN along with AstraZeneca aims to generate large scale awareness and educate people about ways to improve kidney health
Novo Nordisk expands research collaboration for biologic medicines
By IPP Bureau - March 09, 2022
This collaboration has resulted in several high-impact scientific publications describing breakthrough inventions, including the SOMA robotic pill, which has subsequently been licensed exclusively to Novo Nordisk for clinical development
Philips mobile cardiac outpatient telemetry detects Atrial Fibrillation early
By IPP Bureau - March 09, 2022
As an initial remote monitoring diagnostic approach, Philips BioTel Heart MCOT detected 4.6 times more patients with atrial fibrillation compared to implantable loop recorder alone
Novartis, Voyager Therapeutics reach license deal for gene therapy vectors to combat neurological diseases
By IPP Bureau - March 09, 2022
Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders
SII’s Covovax approved for 12-17 years age group
By IPP Bureau - March 09, 2022
The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021
Merck’s KEYTRUDA demonstrates extended relief for patients with resected stage IIB and IIC melanoma
By IPP Bureau - March 08, 2022
New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients
ENTOD Pharmaceuticals launches glaucoma awareness campaign
By IPP Bureau - March 08, 2022
Raising awareness about glaucoma is crucial in India where it is the leading cause of irreversible blindness with at least 12 million people affected and almost 1.2 million people blind from the disease
Dr Sheela Nampoothiri appointed as co-chair of ICMR's Rare Diseases expert committee
By IPP Bureau - March 08, 2022
Dr Ratna Puri from Sir Ganga Ram Hospital, Delhi is the Chairperson of the expert committee.
Organon declares paid time off for all employees on International Women’s Day
By IPP Bureau - March 08, 2022
As the Covid-19 pandemic continues to have a disproportionate impact on women, Organon issues a call to action for other leaders to create opportunities to focus on women’s health
Suvoda unveils new brand to reflect expanded focus in complex clinical trial management
By IPP Bureau - March 08, 2022
Alongside brand refresh, the leading clinical trial technology company announces eConsent and eCOA offerings to better support the patient clinical trial journey
Moderna to set up first mRNA facility in Kenya
By IPP Bureau - March 08, 2022
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
Ankura launches pharmaceutical data integrity solution
By IPP Bureau - March 08, 2022
Data integrity early warning system assists pharmaceutical clients in proactively identifying and managing data integrity challenges in line with regulatory guidelines
Aleor Dermaceuticals receives USFDA approval for Nystatin and Triamcinolone Acetonide ointment
By IPP Bureau - March 08, 2022
Nystatin and Triamcinolone Acetonide ointment is indicated for the treatment of cutaneous candidiasis
LifeCell India initiative to identify breast cancer risk in women
By IPP Bureau - March 08, 2022
The revolutionary genetic test helps screen common genes associated with hereditary breast and ovarian cancer in women above 18 years of age
